These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
We're Not Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
S&P 500 Futures Fall In Premarket Trading; Delta Air Lines, Viking Therapeutics Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Range Resources Corp. (RRC) was up 3.3% in pre-
Express News | Viking Therapeutics Shares Fall 3.9% Premarket After Rival Pfizer Says It Plans to Move Forward With Once-Daily Weight Loss Pill
Is Viking Therapeutics Stock Running Out of Steam?
Oppenheimer's Best 'SMID-cap' Ideas for 2024
Better GLP-1 Biotech Stock: Altimmune Vs. Viking Therapeutics
Small, Mid-size Biotechs Could See M&A Action in H2 - PwC
Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity
Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX).And retail traders should know.We noticed this today when the trades showed up on publicly avail
Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
BTIG analyst Justin Zelin maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 37.8% and a t
Optimistic Outlook for Viking Therapeutics' Obesity Treatments Amid Upcoming Catalysts and Regulatory Progress
A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.
A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June's sharply lower-than-expected services sector activ
Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $110
Jefferies analyst Roger Song maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $110.According to TipRanks data, the analyst has a success rate of 29.1% and
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Trending Stocks Today: Ocean Power Technologies Surges 67.3% Pre-Market
July 2nd - US stocks trending pre-market: Gainers: $Ocean Power Technologies(OPTT.US)$ soars 67.3% to $0.46 with a turnover of $34.22 million. $Roadzen(RDZN.US)$ shoots up 43.81% to $2.33 with a turno
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 33.85% on an annualized basis producing an average annual return of 46.66%. Currently, Viking Therapeutics has a
Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
Stifel analyst Annabel Samimy maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 43.2% and